Can Pulse Oximeters Help Monitor COVID Recovery At Home?

New Post Public Reply Private Reply Replies (0) Message Board
someconcerns
812
Can Pulse Oximeters Help Monitor COVID Recovery At Home? Science Still Says 'Maybe'
Two recent pieces of research on at-home pulse oximetry slightly contradict each other—but still conclude that any form of home monitoring during COVID recovery is beneficial.
By Rachel Murphy
Published on May 23, 2022

Fact checked on May 20, 2022 by Vivianna Shields, a journalist and fact-checker with experience in health and wellness publishing.

Pre-COVID pandemic, pulse oximeters—small devices that measure oxygen levels in your blood—were the farthest thing from a hot commodity. But once the virus started making its rounds, sales of the tools spiked.

Still, more than two full years into the COVID-19 pandemic, science can't seem to agree on whether or not the devices are truly helpful for people at home recovering from the illness. The conflicting views are shown in two recent research articles—both that examined the effectiveness of pulse oximeters for monitoring recovering COVID patients at home—that came to slightly different conclusions.

The first, a study published in the New England Journal of Medicine, concluded that the addition of home pulse oximetry was no more effective than text check-ins from hospital staff in keeping patients alive and out of the hospital again.

However, another piece of research—this one, a viewpoint published in JAMA—found the opposite: That remote monitoring using pulse oximeters was highly effective at keeping patients out of the hospital during their recovery from COVID-19.

While the two studies came to roughly the same conclusion about how remote monitoring of some kind can help save lives and keep patients out of the hospital after a bout of COVID-19, the conflicting views on pulse oximeters might make you wonder: Are the devices helpful or not to have on hand? Here's what to know.

How Pulse Oximeters Work

A pulse oximeter, sometimes known as a pulse ox, is an electronic device that measures the amount of oxygen you have circulating in your blood. Though it's usually attached to the tip of the finger, pulse oximeters can also be attached to the forehead, nose, foot, ears, or toes.

In a matter of seconds, the device can give a heart rate and oxygen saturation reading (SpO2). There are a handful of things that can affect a pulse oximetry reading, including poor circulation, skin pigmentation or thickness, skin temperature, tobacco use, and fingernail polish.

In most healthy individuals, oxygen saturation levels range from 95%–100%. If you're using an at-home pulse oximeter and your oxygen saturation levels drop below 92% you should contact a health care provider; if it drops below 88%, seek emergency medical attention.

For the first study, a randomized trial known as COVID Watch, more than 2,000 participants were assigned to monitor oxygen levels through a pulse oximeter or automated text messages twice a day to self-assess their breathing.

"They were asked two questions," study co-author Anna Morgan, MD, MSc, MSHP, assistant clinical professor at the University of Pennsylvania Perelman School of Medicine, told Health. Participants were asked how they felt compared to 12 hours ago, and depending on the answer, if it was harder than usual for them to breathe. If the patient responded "yes," then a team of clinicians were alerted and the patient was contacted to determine whether they needed to visit the hospital. "They were questions that we felt were very answerable," Dr. Morgan added.

Ultimately, researchers found that patients who received text messages were no worse off than those who used a pulse oximeter. Dr. Morgan added that even anxiety levels among the texting group were roughly the same as those who used the tool.

"There was an expectation of anxiety benefits—that patients would be less anxious if they had a pulse oximeter," Dr. Morgan said. "That really didn't pan out. The levels of anxiety that patients reported were the same."

Meanwhile, the viewpoint published in JAMA found pulse oximeters to be helpful in preventing death in discharged COVID-19 patients, particularly when dealing with a condition known as 'happy' or silent hypoxia, or having low oxygen levels without respiratory distress. Hypoxia, though deadly, can be reversed if caught in time.

Pulse oximeters would be especially useful in those situations since text message monitoring wouldn't reveal a condition for which a patient isn't feeling symptoms, according to viewpoint co-author Peter Pronovost, MD, PhD, FCCM, chief quality and clinical transformation officer at University Hospitals. With pulse oximeters, when oxygen saturation changes significantly or drops below a certain level, hospital staff, theoretically, could be alerted to patients more quickly than through periodic checks.

Although the different points of research may seem at odds with their verdict about the need for pulse oximeters, they agree on the efficacy of remote monitoring of patients. The ability to monitor patients at home can save thousands in medical bills while utilizing readily available tools to hospital systems. Remote monitoring could also help regulate the number of open hospital beds at high volume times.

"We believe that somewhere between 30%–40%, maybe even 50% of hospital admissions can be cared for at home," Dr. Pronovost said. "It's transformative technology. Not only do we have monitoring, but we have an amazing amount of therapies that we can offer at home."

Pronovost says that while his study looked at COVID-19 patients, the technology and monitoring protocols could be applied to several different conditions, including pneumonia, heart failure, and chronic obstructive pulmonary disease (COPD).

Dr. Morgan also said she believes that remote monitoring via text messaging provides new opportunities for at-home care.

"I think the possibilities are endless. I think it's something that all patients can access equally," Dr. Morgan said. "I think that these text message programs are about meeting patients where they are and developing a relationship with them. People like using text messaging, and this is another way we can connect with our patients."

The answer here is murky. Pulse oximeters may only give a partial picture when used without the insight of a medical professional.

According to Dr. Pronovost, the quality of the data from consumer-oriented pulse oximeters can be unreliable—many commercially-available pulse oximeters are unregulated as medical devices, and so their accuracy can be unreliable. (Both research articles above used hospital-grade pulse oximeters that can transmit data to trained professionals). It should also be noted too that some studies have shown pulse oximeters to be less accurate on darker skin tones.

That said, there are still accurate pulse oximeters on the market and readily available. Looking for devices that are FDA-approved are a good starting point, Dr. Pronovost said. However, if you have been diagnosed with a heart issue or pulmonary issue, a hospital-grade pulse oximeter may be a good investment, Dr. Pronovost said.

If you're not up for investing in any kind of pulse oximeter, you can still monitor your health at home—specifically by observing your breathing if you have or have recently had COVID-19. If at any point it feels more difficult to breathe than usual, or if your breathing changes suddenly, it's important to contact a health care provider.

Overall, continuous monitoring of any kind and ongoing communication with a health care provider can help you stay out of the hospital in the long term.

The information in this story is accurate as of press time. However, as the situation surrounding COVID-19 continues to evolve, it's possible that some data have changed since publication. While Health is trying to keep our stories as up-to-date as possible, we also encourage readers to stay informed on news and recommendations for their own communities by using the CDC, WHO, and their local public health department as resources.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DIR Launches ManhattanHockey.com Amid Rangers' 100th Year

Updated Category News Views 66

Digital Information Makes a Bold Play in Sports Media The puck drops in a whole new way today as Digital Information Resources (DIR) decides it's the digital age for hockey. They've tossed their hat into the rink, launching ManhattanHockey.com, wholeheartedly dedicated to fans of the New York Rangers. The timing's no fluke—this year marks the century milestone for the...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 66

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
NetEase Awaits Q3 2026 Results: What's at Stake?

Updated Category News Views 96

D-Day for NetEase: Quarterly Results Incoming We're inching closer to November 19, 2026, and if you hold a piece of NetEase (NASDAQ: NTES), you're probably on pins and needles. This is when the curtains rise on their third-quarter financial results, which they've been fiercely guarding like a high-stakes poker hand. They'll be laying it all out right before the U.S....

Continue Reading
Sysco's Regulatory Hurdle: Investors Eye Jetro Deal Risks

Updated Category News Views 156

Sysco's Tumultuous Day: A Sharp Dive Well, folks, if you're holding onto Sysco shares, you might be feeling the pinch. On November 3, 2026, Sysco Corporation (NYSE: SYY) took a nosedive, dropping 9.3% in a single trading session. The reason? A hefty $29.1 billion acquisition deal that's still caught up in regulatory limbo. The looming merger with Jetro Restaurant Depot...

Continue Reading
Sharon Bowen Honored; e.l.f. Beauty Hits 31 Quarters

Updated Category News Views 24

Markets Stir as NYSE Chair Earns Lifetime Award While the financial world often gets lost in numbers, sometimes it's the people who stand out. NYSE Chair Sharon Bowen is taking the spotlight with her lifetime achievement award, underscoring her game-changing influence in governance. This is more than just a pat on the back; it's a nod to the force she’s been in steering...

Continue Reading
Preplanning Funerals: Choices for Clarity and Comfort

Updated Category News Views 81

Making Clear Plans for the Inevitable Man, if life is certain about one thing, it’s the endgame. And nobody wants to pass the buck on sorting out the details when they’re six feet under. Enter funeral preplanning – a chance to write the script for your own final episode and keep your family out of the weeds when the time comes. Jake Leonetti over at Stone Chapel...

Continue Reading
Ryde Group Faces Fraud Claims: Investor Action Looms

Updated Category News Views 75

Big Trouble in the Stock Market for Ryde Group Well, hold onto your hats, folks—Ryde Group Ltd. is neck-deep in legal hot water. If you thought the stock market was a place of pure strategy and devoid of any drama, think again. Recently, DJS Law Group threw down the gauntlet with a class action lawsuit against Ryde Group (NYSE American: RYDE) for some pretty hefty...

Continue Reading
Hidden Costs of Lineworker and CDL Training in California

Updated Category News Views 71

The True Financial Picture of Skilled Trade Programs Ever wonder why that flashy tuition number doesn't line up with your wallet by the end of your training days? That's the reality smashing aspiring lineworkers and future truck drivers in Northern California right in the face. We're talking about a full breakdown here, beyond what the glossy brochures ever tell you....

Continue Reading
Manulife's Q3 2026: Strong Gains Amid Income Dip

Updated Category News Views 85

Manulife's Resilience in a Volatile Market Trading has a way of keeping folks on their toes. Just when you think you've ridden the bull long enough, it tries bucking you off. That's how it goes for Manulife Financial Corporation (TSX/NYSE/PSE: MFC), as they reported their Q3 2026 results—marking a seesaw of gains and losses. Core Earnings Shine While Net Income Declines...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 46

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Antietam Broadband Debuts Flight Mobile for Local Customers

Updated Category News Views 173

Antietam Broadband Introduces Flight Mobile Antietam Broadband is proudly unveiling Flight Mobile, a new offering that marks a significant addition to its expanding FLIGHT product suite. This high-quality mobile telephone service is exclusively available to Antietam internet customers, further enhancing their experience with reliable connectivity. Features of Flight...

Continue Reading
Netcompany Completes Merger with SDC, Sets Financial Goals

Updated Category News Views 726

Netcompany and SDC Merger Successfully Finalized Sept 2025 marks a significant milestone for Netcompany Group A/S as it officially completes its merger with SDC A/S. This integration, announced earlier in the year, involves merging a newly formed entity, Netcompany Banking Services A/S, with SDC, a move that signifies a powerful alignment in the financial services sector....

Continue Reading
Clover Leaf Capital Corp. Holds Special Meeting to Discuss Future

Updated Category News Views 236

Clover Leaf Capital Corp. (Nasdaq: CLOE) stirred the pot in 2024 with its special meeting, aimed at discussing a key business combination. Traders on the floor sensed some tension; adjournment of the stockholder meeting wasn't exactly a confidence booster. Special Meeting Debacle: What's Next for CLOE? When Clover Leaf gathered its stockholders, it wasn’t to rally them...

Continue Reading
Exploring the Future of the Cancer Cell Analysis Market

Updated Category News Views 46

Introducing the Cancer Cell Analysis Market The Cancer Cell Analysis market is poised for significant growth, projected to reach approximately USD 23.31 billion by 2033, driven by various factors establishing a robust landscape for advancements in cancer diagnostics and treatments. The demand for innovative technologies in healthcare has never been greater, providing a...

Continue Reading
DJT Stock Takes a Hit After Trump's Significant Share Move

Updated Category News Views 234

DJT Stock Experiences Significant Decline Trump Media & Technology Group Corp has faced a notable downturn in its stock value, with shares plummeting by 5.31% during pre-market trading. This drastic change is closely tied to a significant decision made by Donald Trump regarding his shares in the company. The Decision Behind the Decline What Happened? On a recent trading...

Continue Reading